Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
![Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity | Pharmacological Reviews Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/56/2/185/F1.large.jpg)
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity | Pharmacological Reviews
![Development and Validation of a Diagnostic Nomogram to Predict the Anthracycline-Induced Early Cardiotoxicity in Children with Hematological Tumors | Cardiovascular Toxicology Development and Validation of a Diagnostic Nomogram to Predict the Anthracycline-Induced Early Cardiotoxicity in Children with Hematological Tumors | Cardiovascular Toxicology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12012-022-09755-5/MediaObjects/12012_2022_9755_Fig3_HTML.png)
Development and Validation of a Diagnostic Nomogram to Predict the Anthracycline-Induced Early Cardiotoxicity in Children with Hematological Tumors | Cardiovascular Toxicology
![Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer | JCO Clinical Cancer Informatics Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer | JCO Clinical Cancer Informatics](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/cci/2021/cci.2021.5/cci.21.00099/20220404/images/large/cci.21.00099t2.jpeg)
Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer | JCO Clinical Cancer Informatics
![Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/63228398-a273-47e0-9a5b-f60275c5b4c0/jah35987-fig-0003.png)
Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association
![Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/8a90e6e7-ce30-431f-81d9-9d2904ef50f3/jah35987-fig-0002.png)
Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association
![Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.64.33.issue-32/jco.2015.61.5187/20161107/images/medium/zlj03215-5547-t02.jpeg)
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
![Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.64.33.issue-32/jco.2015.61.5187/20161107/images/medium/zlj03215-5547-t0a2.jpeg)
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
![Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/7e223d63-2e87-4bc9-a4c7-7e1a453a019a/jah35987-fig-0001.png)
Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta‐Analysis of Placebo Arms From Randomized Controlled Trials | Journal of the American Heart Association
![Molecules | Free Full-Text | 2,4-Dinitrophenol as an Uncoupler Augments the Anthracyclines Toxicity against Prostate Cancer Cells Molecules | Free Full-Text | 2,4-Dinitrophenol as an Uncoupler Augments the Anthracyclines Toxicity against Prostate Cancer Cells](https://www.mdpi.com/molecules/molecules-27-07227/article_deploy/html/images/molecules-27-07227-g001.png)
Molecules | Free Full-Text | 2,4-Dinitrophenol as an Uncoupler Augments the Anthracyclines Toxicity against Prostate Cancer Cells
![Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.64.33.issue-32/jco.2015.61.5187/20161107/images/medium/zlj03215-5547-t01.jpeg)
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
![Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.64.33.issue-32/jco.2015.61.5187/20161107/images/medium/zlj03215-5547-t0a1.jpeg)
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens - Document - Gale Academic OneFile
![Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantrone. - PDF Free Download Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantrone. - PDF Free Download](https://docplayer.net/docs-images/69/61793188/images/7-0.jpg)